» Authors » Jakub Podolec

Jakub Podolec

Explore the profile of Jakub Podolec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 713
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Niewiara L, Kleczynski P, Guzik B, Szolc P, Podolec J, Baran J, et al.
Kardiol Pol . 2025 Feb; PMID: 39932379
Background: Coronary microcirculatory dysfunction (CMD) is an emerging topic in the contemporary treatment of patients with chronic coronary syndromes (CCS), with influence both on diagnosis and patient outcome. Data on...
2.
Podolec J, Kleczynski P, Piechocki M, Okarski M, Lizonczyk K, Szkodon K, et al.
J Clin Med . 2024 Nov; 13(22). PMID: 39598055
: Depression is a known factor in poor cardiovascular outcomes but is often underassessed in cardiac units. This study evaluates the impact of depression on cardiovascular outcomes in patients undergoing...
3.
Piechocki M, Okarski M, Szkodon K, Lizonczyk K, Zachara J, Skiba M, et al.
Kardiol Pol . 2024 Aug; 82(10):992-995. PMID: 39140659
No abstract available.
4.
Maciejewski D, Nowak K, Wawak M, Karcinska A, Tekieli L, Trystula M, et al.
Bratisl Lek Listy . 2024 Apr; 125(5):289-298. PMID: 38624053
Cardio-cerebral infarction (CCI) is a term coined to describe concomitant myocardial infarction and acute ischemic stroke. Acute myocardial infarction and stroke, as separate events, constitute some of the most important...
5.
Piechocki M, Przewlocki T, Pieniazek P, Trystula M, Podolec J, Kablak-Ziembicka A
J Clin Med . 2024 Apr; 13(5). PMID: 38592348
Aging is a key risk factor for atherosclerosis progression that is associated with increased incidence of ischemic events in supplied organs, including stroke, coronary events, limb ischemia, or renal failure....
6.
Piechocki M, Przewlocki T, Pieniazek P, Trystula M, Podolec J, Kablak-Ziembicka A
J Clin Med . 2024 Apr; 13(5). PMID: 38592280
Atherosclerosis is a generalized and progressive disease. Ageing is a key risk factor for atherosclerosis progression that is associated with the increased incidence of ischemic events in supplied organs, including...
7.
Kablak-Ziembicka A, Badacz R, Okarski M, Wawak M, Przewlocki T, Podolec J
Arch Med Sci . 2023 Sep; 19(5):1360-1381. PMID: 37732050
MicroRNAs are small non-coding post-translational biomolecules which, when expressed, modify their target genes. It is estimated that microRNAs regulate production of approximately 60% of all human proteins and enzymes that...
8.
Niewiara L, Kleczynski P, Guzik B, Szolc P, Baran J, Podolec J, et al.
Cardiol J . 2022 Nov; 31(2):185-192. PMID: 36342032
Background: Type 2 diabetes (DM) is a common comorbidity associated with cardiovascular disease, especially when poor glucose control is present. Extracardiac microcirculatory complications prevalence is well documented, however coronary microcirculatory...
9.
Legutko J, Niewiara L, Guzik B, Szolc P, Podolec J, Nosal M, et al.
Front Cardiovasc Med . 2022 Oct; 9:1003067. PMID: 36277746
Background: Resting full-cycle ratio (RFR) is an alternative to fractional flow reserve (FFR) for the evaluation of borderline coronary artery lesions. Although FFR and RFR results are discordant in some...
10.
Valgimigli M, Frigoli E, Vranckx P, Ozaki Y, Morice M, Chevalier B, et al.
J Am Coll Cardiol . 2022 Aug; 80(8):766-778. PMID: 35981821
Background: Nonadherence to antiplatelet therapy after percutaneous coronary intervention (PCI) is common, even in clinical trials. Objectives: The purpose of this study was to investigate the impact of nonadherence to...